- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/22 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
Patent holdings for IPC class C07D 251/22
Total number of patents in this class: 95
10-year publication summary
|
9
|
9
|
4
|
7
|
4
|
9
|
5
|
10
|
5
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Tetra Discovery Partners, LLC | 11 |
7 |
| Merck Patent GmbH | 5825 |
6 |
| Bayer Intellectual Property GmbH | 2537 |
6 |
| Japan Tobacco Inc. | 3486 |
5 |
| Samsung Display Co., Ltd. | 33684 |
4 |
| BASF SE | 20616 |
4 |
| The Brigham and Women's Hospital, Inc. | 2149 |
3 |
| Kyoto University | 2775 |
3 |
| Yuma Therapeutics, Inc. | 5 |
3 |
| Merck KGAA | 2497 |
2 |
| Syngenta Crop Protection AG | 5891 |
2 |
| Agios Pharmaceuticals, Inc | 216 |
2 |
| Lead Discovery Center GmbH | 58 |
2 |
| National Institute of Biological Sciences, Beijing | 96 |
2 |
| Purdue Pharma L.P. | 500 |
2 |
| Guangzhou ChinaRay Optoelectronic Materials Ltd. | 148 |
2 |
| Oxford Drug Design Limited | 8 |
2 |
| LG Chem, Ltd. | 17464 |
1 |
| The Regents of the University of California | 19681 |
1 |
| Bayer Pharma AG | 1058 |
1 |
| Other owners | 35 |